Progression-free survival and safety at 3.5 years of follow-up : results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary
Source
Future oncology - ISSN 1479-6694- (2024) p.
Malnutrition prevalence in cancer patients in Belgium : the ONCOCARE study
Source
Supportive care in cancer - ISSN 0941-4355-32:2 (2024) p. 1-9
The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
Source
Case Reports in Oncology - ISSN 1662-6575-16:1 () p. 453-460
EV-301 long-term outcomes : 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinoma
Source
Annals of oncology - ISSN 0923-7534-34:11 (2023) p. 1047-1054
Progression-free survival and safety at 3.5 years of follow-up : results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer
Source
European journal of cancer - ISSN 0959-8049-189 (2023) p. 1-13